This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Laboratory Corp of America Hldgs (LH)

NYSE: Health Care

  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: 19.4791
  • Price Earnings Comparisons:
    LH Sector Avg. S&P 500
    19.48 19.50 25.85
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    7.42% 27.90% 26.47%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 2.40 0.16 0.05
    Net Income -1.60 0.01 0.00
    EPS 4.40 0.17 0.05
  • Earnings for LH:
    EBITDA 1.24B
    REVENUE 5.81B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.63 $1.72 $6.78 $7.30
Number of Analysts 14 6 14 14
High Estimate $1.71 $1.83 $6.87 $7.50
Low Estimate $1.59 $1.65 $6.75 $6.97
Prior Year $1.61 $1.51 $6.95 $6.78
Growth Rate (Year over Year) 1.38% 14.02% -2.37% 7.65%
LH News

LH Laboratory Corp of America Hldgs

Analysts Ratings for LH

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 7 7 8
Moderate Buy 1 0 0 0
Hold 5 7 9 9
Moderate Sell 0 0 0 0
Strong Sell 1 2 2 2
GET LH ANALYST REPORT

Brokerage Partners

LH Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs